Table 3.
TAM (ng/g) | DMT (ng/g) | 4-OH (ng/g) | Endoxifen (ng/g) | BMI | Months on TAM | |
---|---|---|---|---|---|---|
Tumor recurrent patients (n = 16) | 122 ± 25.2 | 324 ± 103 | 2.13 ± 0.604 | 19.2 ± 5.08 | 26.4 | 26 |
Tumor non-recurrent patients (n = 8) | 147 ± 51.7 | 1,256 ± 282.8 | 9.75 ± 4.62 | 94.6 ± 41.0 | 28.6 | 22 |